摘要
对1例危重型新型冠状病毒肺炎患者在治疗期间发生难治性高血糖的原因及治疗进行了回顾性分析,表明新型冠状病毒感染对糖代谢会产生损害,在临床治疗中应加强血糖的监测控制。
The cause and treatment of refractory hyperglycemia in a critically ill coronavirus disease 2019(COVID-19)patient during treatment were analyzed retrospectively,indicating that novel coronavirus infection may cause damage to glucose metabolism,so the monitoring and control of blood glucose should be strengthened in clinical treatment.
作者
沈祖波
谢芳
钟俊
黄思堃
唐洪波
吉丹丹
傅小云
Shen Zubo;Xie Fang;Zhong Jun;Huang Sikun;Tang Hongbo;Ji Dandan;Fu Xiaoyun(Department of Critical Care Medicine,Ezhou Central Hospital,Ezhou 436000,China;Respiratory Intensive Care Unit,Ezhou Central Hospital,Ezhou 436000,China;Department of Critical Care,Guiyang Hospital of Guizhou Aviation Industry Group,Guiyang 510530,China;Department of Emergency,Qiandongnan People′s Hospital,Kaili 556000,China;Department of Critical Care Medicine,the First People′s Hospital of Zunyi City,Zunyi 563000,China;Department of Critical Care Medicine,the First People′s Hospital of Bijie City,Bijie 551700,China;Department of Critical Care Medicine,Affiliated Hospital of Zunyi Medical University,Zunyi 563003,China)
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2020年第6期512-514,共3页
Chinese Journal of Endocrinology and Metabolism
关键词
新型冠状病毒肺炎
难治性高血糖
治疗
Coronavirus disease 2019
Refractory hyperglycemia
Treatment
